MyAverix Finance
ST · Healthcare
Medivir AB (MVIR)
Biotechnology
Medivir AB (MVIR) is listed on ST in the Healthcare sector. Industry: Biotechnology. As of 2026-05-24, reported market cap is $1.02B, P/E ratio is 25.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for MVIR
Medivir AB (MVIR) — FAQ
What is Medivir AB's market cap?
Medivir AB (MVIR) has a reported market cap of $1.02B (data as of 2026-05-24).
What is MVIR's P/E ratio?
The price-to-earnings (P/E) ratio for Medivir AB (MVIR) is 25.00 (data as of 2026-05-24).
Does Medivir AB pay a dividend?
Dividend yield is not available in the current snapshot for Medivir AB (MVIR). Check the MyAverix Finance app for the latest dividend data.
What sector is Medivir AB in?
Medivir AB (MVIR) is classified in the Healthcare sector (Biotechnology industry).
What exchange is MVIR listed on?
MVIR is listed on ST.
What is Medivir AB's net margin?
Medivir AB (MVIR) reports a net margin of 0.0% (data as of 2026-05-24).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.